Abstract
When there is no vaccine for a disease, ‘Test, Trace, Treat/Isolate’ is the public health go‐to directive. During the COVID‐19 pandemic, mobile phone apps are designed to improve on this. But COVID‐apps have not been effective as a public health tool. Countries spend millions to develop them, yet they have been shown to have terrible return on investment. This commentary explores why COVID‐apps are generally championed and provides three brief case studies (Germany, Sierra Leone, Canada) of non‐app public health success. In conclusion, I argue that we need to get our public health care priorities straight: Better and more testing; increased investment in manual contact tracing and treatments; hospitalization when necessary; and wrap‐around care – assistance with groceries, cleaning, child‐ or eldercare responsibilities, telehealth doctor appointment hookups – for sick people in home isolation.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
